Logo do repositório
 
Publicação

Recomendações do Grupo Português do Mieloma Múltiplo para Tratamento do Mieloma Múltiplo

2023-07-03Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorJoão, Cristina
dc.contributor.authorBergantim, Rui
dc.contributor.authorSantos, Joana
dc.contributor.authorAfonso, Celina
dc.contributor.authorBernardo, Paulo
dc.contributor.authorCoelho, Henrique
dc.contributor.authorCosta, Carlos
dc.contributor.authorEsteves, Graça
dc.contributor.authorFreitas, José Guilherme
dc.contributor.authorGerivaz, Rita
dc.contributor.authorJorge, Ana
dc.contributor.authorMacedo, Ana
dc.contributor.authorMontalvão, Ana
dc.contributor.authorNeves, Manuel
dc.contributor.authorPedrosa, Claúdia L.
dc.contributor.authorPereira, Susana
dc.contributor.authorRoque, Adriana
dc.contributor.authorSeabra, Patrícia
dc.contributor.authorM Silva, Helena
dc.contributor.authorSilveira, Maria P.
dc.contributor.authorTomé, Ana
dc.contributor.authorTrigo, Fernanda
dc.contributor.authorSarmento, Ana Bela
dc.contributor.authorLúcio, Paulo
dc.contributor.authorGeraldes, Catarina
dc.contributor.institutionNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
dc.contributor.pblBiblioteca Nacional de Portugal, Centro de Estudos Históricos, CELOM
dc.date.accessioned2023-07-19T22:16:08Z
dc.date.available2023-07-19T22:16:08Z
dc.date.issued2023-07-03
dc.description.abstractThe treatment of multiple myeloma has profoundly changed with the introduction of several innovative therapies. The optimization of therapeutic sequencing through the combined use of the various drugs developed in recent years and the attention given to the characteristics of patients have allowed the reduction of toxicities and increased survival and quality of life of patients with multiple myeloma. These treatment recommendations from the Portuguese Multiple Myeloma Group offer guidance for first-line treatment and progression/relapse situations. These recommendations are given highlighting the data that justify each choice and referring to the respective levels of evidence that support these options. Whenever possible, the respective national regulatory framework is presented. These recommendations constitute an advance towards the best treatment of multiple myeloma in Portugal.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent10
dc.format.extent558338
dc.identifier.doi10.20344/amp.19037
dc.identifier.issn1646-0758
dc.identifier.otherPURE: 66755113
dc.identifier.otherPURE UUID: 3104e187-e9b1-47aa-a451-3297d8d9deac
dc.identifier.otherScopus: 85164288806
dc.identifier.otherPubMed: 37429590
dc.identifier.otherWOS: 001081153400010
dc.identifier.urihttp://hdl.handle.net/10362/155556
dc.identifier.urlhttps://www.scopus.com/pages/publications/85164288806
dc.language.isopor
dc.peerreviewedyes
dc.subjectMultiple Myeloma/drug therapy
dc.subjectPortugal
dc.subjectGeneral Medicine
dc.titleRecomendações do Grupo Português do Mieloma Múltiplo para Tratamento do Mieloma Múltiplopt
dc.title.alternativeMultiple Myeloma Treatment Guidelines by the Portuguese Group of Multiple Myelomaen
dc.typejournal article
degois.publication.firstPage517
degois.publication.issue7-8
degois.publication.lastPage526
degois.publication.titleActa Medica Portuguesa
degois.publication.volume36
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
517_526.pdf
Tamanho:
545.25 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

NMS - Artigos em revista nacional com arbitragem científica